CTTH insider buying and SEC filings, explained
CTT Pharmaceutical Holdings, Inc. · CIK 1035422
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 26, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 5,880 shares at $0.0570 ($335), reported as a purchase (code P). Holdings up <1% to 9,442,536 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 26, 2026, 9:05 PM ET |
| Oct 15, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 2,000 shares at $0.0570 ($114), reported as a purchase (code P). Holdings up <1% to 9,436,656 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 19, 2026, 5:22 PM ET |
| Oct 6, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 3,700 shares at $0.0550 ($204), reported as a purchase (code P). Holdings up <1% to 9,433,656 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 6, 2026, 5:24 PM ET |
| Sep 22, 2026 | Purchase (code P) Amended filing | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 10,100 shares at $0.0500 ($505), reported as a purchase (code P). Holdings up <1% to 9,424,556 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 22. | SEC filing Filed Sep 29, 2026 |
| Sep 28, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 3,400 shares at $0.0600 ($204), reported as a purchase (code P). Holdings up <1% to 9,429,956 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 28, 2026 |
| Sep 16, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO and Director) bought 10,900 shares at $0.0500 ($545), reported as a purchase (code P). Holdings up <1% to 9,414,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 10, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 3,500 shares at $0.0500 ($175), reported as a purchase (code P). Holdings up <1% to 9,400,556 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
| Sep 4, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 9,800 shares at $0.0500 ($490), reported as a purchase (code P). Holdings up <1% to 9,397,056 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 4, 2026 |
| Sep 2, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 3,000 shares at $0.0500 ($150), reported as a purchase (code P). Holdings up <1% to 9,387,256 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
| Aug 31, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 3,500 shares at $0.0500 ($175), reported as a purchase (code P). Holdings up <1% to 9,384,256 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 24, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 2,100 shares at $0.0600 ($126), reported as a purchase (code P). Holdings up <1% to 9,360,756 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 24, 2026 |
| Aug 20, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 11,500 shares at $0.0500 ($575), reported as a purchase (code P). Holdings up <1% to 9,378,656 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 19, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 10,000 shares at $0.0600 ($600), reported as a purchase (code P). Holdings up <1% to 9,365,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 19, 2026 |
| Aug 14, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 1,800 shares at $0.0600 ($108), reported as a purchase (code P). Holdings up <1% to 9,355,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Aug 7, 2026 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 7,700 shares at $0.0700 ($539), reported as a purchase (code P). Holdings up <1% to 9,353,656 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Dec 17, 2025 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 8,300 shares at $0.0600 ($498), reported as a purchase (code P). Holdings up <1% to 7,845,956 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Nov 20, 2025 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (Director) bought 200,000 shares at $0.0400 ($8K), reported as a purchase (code P). Holdings up 6% to 3,734,003 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Purchase (code P) | CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) bought 62,900 shares at $0.0400 ($3K), reported as a purchase (code P). Holdings up 1% to 7,837,656 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CTTH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.